Search clinical trials for: syndecan-1

Total 47091 results

Assistance Publique - Hôpitaux de Paris

Completed

Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users (VIGICANN)

Occasional (1-2 Joints Per Week) and Chronic (1-2 Joints Per Day) Cannabis Users

France
JKT Biopharma Co., Ltd.

Recruiting

The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects

Phase 1

China
Graviton Bioscience Corporation

Completed

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects

Phase 1

United States
Sanofi

Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
Genzyme, a Sanofi Company

Completed

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery. (C-MUST)

Adhesion Prevention

France
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Healthy

Germany
UCB Pharma SA

Completed

Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations

Healthy

China
UCB Pharma

Completed

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

Human Volunteers

China
Xu J

Recruiting

New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA

Obstructive Sleep Apnea

China
Chita State Regional Clinical Hospital Number 1

Recruiting

Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 (SPIDEX-II)

Coronavirus Infection | Pneumonia, Viral

Russian Federation
Azienda U.S.L. 1 di Massa e Carrara

Completed

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2016)

Post Partum Haemorrhage

Italy
Wu Wenjun-1
Xidian University

Unknown

Real-time NIRS Neurofeedback Regulating Brain Cognitive Function in Obese Individuals

Obesity | Neurofeedback

China
Yaounde Central Hospital
University of Yaounde 1

Completed

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Cameroon
Eli Lilly and Company

Completed

A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

United States
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3819469 in Healthy Participants

Healthy

Singapore
UCB Celltech

Completed

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis

Mild to Moderate Psoriasis

United Kingdom
UCB Celltech
Parexel

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects

Healthy Volunteers

United Kingdom
UCB Pharma SA

Completed

Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers

Healthy Volunteers

Netherlands
UCB Pharma

Completed

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Human Volunteers

China
UCB Pharma
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Healthy Volunteers

Germany
Thomayer University Hospital
Masaryk University

Recruiting

Czech AATD Registry

Alpha-1-antitrypsin Deficiency

Czechia
Eli Lilly and Company

Recruiting

A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants

Healthy

China
Eli Lilly and Company

Recruiting

A Study of LY3873862 in Healthy Participants

Healthy

United Kingdom
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

Obesity | Overweight

Spain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
Loxo Oncology, Inc.
Eli Lilly and Company

Active, not recruiting

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)

Medullary Thyroid Cancer

United States, Canada, Spain, China, Australia, Japan, India, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, Italy, Israel, Greece, United Kingdom, Belgium, Poland, Russian Federation
Eli Lilly and Company

Active, not recruiting

A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

Healthy | Alzheimer Disease

United States, Japan
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial (SUMMIT)

Obesity | Heart Failure With Preserved Ejection Fraction (HFpEF)

China, United States, Taiwan, Mexico, Brazil, Puerto Rico, Argentina, Israel, India, Russian Federation
Eli Lilly and Company

Active, not recruiting

A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (RESOLUTION-1)

Immune System Diseases | Autoimmune Diseases | Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Connective Tissue Diseases | Rheumatoid Arthritis

United States, Spain, China, Mexico, Puerto Rico, Japan, Canada, Argentina, Poland, Hungary, Greece
Eli Lilly and Company

Active, not recruiting

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

Ulcerative Colitis

Spain, United States, China, Australia, Austria, Japan, Hungary, Taiwan, Russian Federation, Canada, Korea, Republic of, Italy, Belgium, Poland, Switzerland, Argentina, India, Israel, Latvia, Ukraine, Denmark, Mexico, Romania, Malaysia, Netherland... and more
Eli Lilly and Company

Active, not recruiting

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (postMONARCH)

Neoplasm Metastasis | Breast Neoplasm

United States, Hungary, Italy, Czechia, Taiwan, Turkey, Belgium, Spain, Korea, Republic of, Israel, Argentina, Greece, France, Mexico, Sweden, Denmark, Poland
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) (SURPASS-SWITCH)

Type 2 Diabetes

United States, Belgium, Germany, Mexico, Romania
Eli Lilly and Company

Active, not recruiting

A Study of LY3561774 in Participants With Mixed Dyslipidemia (PROLONG-ANG3)

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hyperlipoproteinemia

United States, Mexico, Poland, Canada, Turkey, Japan, Argentina
Eli Lilly and Company

Completed

A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes (RescuiNGkids)

Type 1 Diabetes

United States
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events (KRAKEN)

Lipoprotein Disorder

Australia, China, Hungary, Brazil, Japan, Germany, Netherlands, United States
Eli Lilly and Company

Completed

A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia

Hypertriglyceridemia

Singapore
Eli Lilly and Company

Active, not recruiting

A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Obesity | Overweight

China
Eli Lilly and Company

Completed

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Diabetes Mellitus, Type 2

India
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

Diabetes Mellitus, Type 2 | Type 2 Diabetes

United States
Eli Lilly and Company

Completed

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

China
Eli Lilly and Company

Completed

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Healthy | Renal Insufficiency

United States
National University of Singapore

Recruiting

Exploration of Women's Experiences and Technology Usage Before, During, and After Pregnancy in Singapore

Pregnancy Related

Singapore
Conor Medsystems

Terminated

CoStar Catheter System Evaluation (CONCISE)

Symptomatic Ischemic Heart Disease

Germany
Istanbul Medipol University Hospital

Completed

Comparison of the Effectiveness of Different Home Exercise Programs

Cognitive Function 1, Social

Turkey
University of Maryland, Baltimore
University of Utah

Completed

Assessing Online Interventions for Men's' Mental Health and Wellbeing

Mental Health Wellness 1

United States
L'Agence des Nouvelles Interventions Sociales et...
Université du Québec a Montréal; Institut national de prevention et d'education...

Completed

Evaluation of the French Maternal and Child Protection Services From 11 French Territories That Have Received Common Intervention Guidelines (PANJO)

Parent-Child Relations | Parents | Mental Health Wellness 1 | Maltreatment by Parent

France
Universitair Ziekenhuis Brussel

Terminated

Body Composition, Bone Health and Hormonal Status in HIV-1-infected Individuals (BONBO)

HIV-1 | Treatment-naïve

Belgium
Shanghai International Medical Center

Unknown

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach)

Advanced Solid Tumor | PD-1 Antibody | CAR-T Cells

China
Filip Krag Knop
University of Copenhagen

Completed

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion

Denmark

Search clinical trials for: syndecan-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations